CD8+/Granzyme B+/Ki67+ also trended higher in responders compared with nonresponders, whereas overall CD8+ cell density was comparable between responders and nonresponders in both the tumor and stromal compartments and in the total tumor (Fig. 2). The gene discussed is CD8A; the disease is neoplasm.